Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
37.47
-0.68 (-1.78%)
Nov 20, 2026, 3:00 PM CST
SHA:600329 Market Cap
SHA:600329 has a market cap or net worth of 24.55 billion as of November 20, 2026. It is the 4,257th most valuable company in the world and the 583rd biggest in China. Its market cap has decreased by 20.17% in one year.
Market Cap
24.55B
Enterprise Value
22.89B
Revenue
4.67B
Global Rank
Country Rank
#583 China
PE Ratio
32.24
ChartMarket Cap Chart
Since June 6, 2001, SHA:600329's market cap has increased from 6.92B to 24.55B, an increase of 255.04%. That is a compound annual growth rate of 5.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 24.55B | -20.23% |
| Dec 31, 2025 | 30.78B | 48.69% |
| Dec 31, 2024 | 20.70B | -6.43% |
| Dec 29, 2023 | 22.12B | 21.24% |
| Dec 30, 2022 | 18.25B | -6.30% |
| Dec 31, 2021 | 19.47B | 73.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Changchun High-Tech Industry (Group) | 29.53B |
| Shenzhen Salubris Pharmaceuticals | 29.30B |
| Hubei Jumpcan Pharmaceutical | 28.85B |
| Dizal (Jiangsu) Pharmaceutical | 27.59B |
| Shijiazhuang Yiling Pharmaceutical | 25.76B |
| Livzon Pharmaceutical Group | 24.86B |
| Zhejiang Huahai Pharmaceutical | 24.19B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 23.01B |